We analyzed the spectral components of RR interval variability under controlled respiration (15 location of diseased coronary arteries. In these studies, the vagal cardiac function has been assessed by heart rate responses to tilting, the Valsalva maneuver, facial water immersion, or deep breathing. These conventional methods inflict a temporary imbalance on the cardiovascular system,9 and the data can be considerably affected by many hemodynamic control factors other than the vagal cardiac function. The purpose of this study was to investigate the relation between the autonomic cardiac function and the clinical and angiographic features of CAD. We evaluated the autonomic cardiac function by power spectral analysis of heart rate variability.9-14 Heart rate power spectral density in humans contains two major components, reflecting respiratory sinus arrhythmia (RSA) and a 0.04-0.15 -Hz fluctuation in the cardiovascular system (Mayer wave-like sinus arrhythmia [MWSA]).13-16 The magnitudes of these two components, respectively, provide quantitative and specific indices of vagal cardiac function and sympathetic cardiac function with vagal modulation.16-'9
Ithough many recent studies1-4 have demon-A strated that reduced vagal cardiac function in patients with coronary artery disease (CAD) is a significant predictor of sudden coronary death and postinfarction mortality, the mechanism for the reduction in the vagal cardiac function in CAD is unknown. Earlier studies5-8 have reported that the vagal cardiac function is commonly impaired in CAD; however, few of them have revealed any relation between impairment in the vagal cardiac function and various features of CAD, which include left ventricular function, angiographic severity, and location of diseased coronary arteries. In these studies, the vagal cardiac function has been assessed by heart rate responses to tilting, the Valsalva maneuver, facial water immersion, or deep breathing. These conventional methods inflict a temporary imbalance on the cardiovascular system,9 and the data can be considerably affected by many hemodynamic control factors other than the vagal cardiac function.
The purpose of this study was to investigate the relation between the autonomic cardiac function and the clinical and angiographic features of CAD. We evaluated the autonomic cardiac function by power spectral analysis of heart rate variability.9-14 Heart rate power spectral density in humans contains two major components, reflecting respiratory sinus arrhythmia (RSA) and a 0.04-0. Disease of the American Heart Association, and only the luminal narrowing in the following segments was used in the final assessment: segments 1-3 for the right coronary artery, segments 6 and 7 for the left anterior descending branch, segments 11 and 12 for the circumflex branch, and segment 5 for the left main coronary artery. According to the angiographic severity, the patients were divided into three groups as follows: group N, no disease or narrowing less than 50%; group S, 50% or greater luminal narrowing of a single major coronary artery; group M, 50% or greater narrowing of multiple coronary arteries or the left main coronary artery. Additionally, the presence of significant stenosis (50% or more luminal narrowing) proximal to the origins of or within the sinoatrial node artery and the atrioventricular node artery was also evaluated.
The left ventricular end-diastolic pressure (LVEDP) was measured during the catheterization, and the left ventricular ejection fraction (LVEF) was calculated from the left ventricular cineangiograms using the area-length method. 23 Statistical Analysis
The differences in mean values between the groups, except for the heart rate spectral variables, were assessed by one-way analysis of variance followed by the Bonferroni modification of the t test, and the differences in distributions were evaluated by the Ad test with the Yates' correction. Comparisons of the spectral variables among groups were adjusted for the effects of age and sex and assessed by analysis of covariance for general linear models (least-square means method) by means of the STATISTICAL ANALY-SIS SYSTEMS (SAS Institute Inc., Cary, North Carolina). The effects of LVEDP and LVEF on the CCVRSA were assessed by partial correlation coefficients (age partialed out). The relations between the CCVRSA and age were assessed by linear regression analysis (least-squares method). A p value less than 0.05 was considered significant. Table 1 shows the population and hemodynamic data of the control group (group C) and the three patient groups divided by the angiographic severity of CAD. Twenty-one patients (38%) had no significant CAD (11 normal coronary and 10 nonsignificant CAD) (group N), 21 (38%) had one-vessel disease (five right coronary artery, 10 left anterior descending, and six circumflex branch disease) (group S), and 14 (24%) had multivessel disease (eight two-vessel, three three-vessel, and three left main coronary artery disease) (group M).
Results

Cardiac Catheterization
In 33 patients (59%), the sinoatrial node artery was found to originate from the circumflex branch and, in the remaining 23 (41%), from the right coronary artery. The significant stenosis proximal to the origin of or within the artery was found in four patients all belonging to group M. In all patients, the atrioventricular node artery was found to originate from the right 
Effects ofAngiographic Severity on Heart Rate
Power Spectrum The RR interval functions and their power spectral densities of representative male patients who are about the same age and have various angiographic severities of CAD are shown in Figure 2 . The magnitude of heart rate variability, particularly that of the respiratory component, decreases with advancing angiographic severity. This is demonstrated more clearly by the reduction in area of the RSA peak (at 0.25 Hz equivalent) in the power spectral density.
The CCVRSA showed a significant negative correlation with age in both control and patient groups (r= -0.30, -0.48, -0.37, and -0.82 for groups C, N, S, and M, respectively) ( Figure 3) . Additionally, the mean age and the gender distribution differed significantly among the four groups (Table 1 ). Thus, we 0 100 200 SeC 300 assessed the effects of angiographic severity on heart rate spectral variables after adjusting for the effect of age and sex by analysis of covariance. The mean RR interval, the CCVRSA, and the MWSA-to-RSA ratio were affected by age (p=0.0012, 0.0001, and 0.0281, respectively), and the CCVRSA and the MWSAto-RSA ratio were affected by sex (p=0.0290 and 0.0192, respectively). After adjusting for the effect of these covariates, the CCVRSA in the patient groups decreased in the order of group N first, then group S, and then group M (p=0.0001), with the value of group N being no different from that of group C (Table 2) . On the other hand, the CCVMWSA was smaller only in group M, as opposed to that in groups N and C (p=O0.0462). The RR interval, RR variance, and MWSA-to-RSA ratio did not differ significantly between these groups. Additionally, the right panel of Figure 3 shows the distribution of CCVRSA in groups N, S, and M by age, with the lower 95% prediction limit for the age relation of the normal controls (group C). Eight patients in group M (57%), three patients in group S (14%), and only one patient in group N (5%) had a CCVRSA below the prediction limit.
Effect of Clinical and Angiographic Features on CCVRSA
The CCVRSA was unaffected by the presence of previous myocardial infarction. After adjusting for the effect of age and sex, we found no significant difference in the CCVRSA between the patients with previous myocardial infarction and those without in any group (Table 3) .
The CCVRSA was also unrelated to the stenosis of any specific coronary artery. Dividing the patients in group S by the location of their diseased vessels, we found no significant difference in CCVRSA with regard to the location. Also, the CCVRSA was unaffected by the presence of significant stenosis proximal to the origin of or within the sinoatrial node artery or the atrioventricular node artery.
The subjects in this study had no electrocardiographic abnormalities other than the Q waves and ST-T changes, except that only two patients in group N presented findings of left ventricular hypertrophy. The age-and sex-adjusted CCVRSA in these two patients were 1.71% and 1.94%. Additionally, we discontinued all medication for at least 3 days before the study. Although ,3-blockers and digitalis, which had been administered in two patients in group M, might have certain effects on autonomic cardiac regulation even after 3 days of abstinence, their age-and sex-adjusted CCVRSA values, 0.94% and 0.63%, did not deviate from the distribution of the value for the other patients in group M.
Effect of Left Ventricular Function
The CCVRSA was also unaffected by the LVEDP or LVEF (Table 4) . When age was partialed out, the partial correlation coefficient of the CCVRSA with these variables was not significant in any group.
Discussion
This study demonstrated the relation between the spectral components of heart rate variability and the clinical and angiographic features of CAD. We found that the CCVRSA is reduced in CAD and that the reduction correlates with the angiographic severity but not with the other CAD features, including the presence of previous myocardial infarction, location of diseased coronary arteries, and indices of left ventricular function. reproducibility.1618 Thus, our observation of changes in the CCVRSA in CAD indicates that CAD is associated with a reduction in the vagal cardiac function correlative to the angiographic severity. We also found in this study that the CCVMWSA decreased only in multivessel disease, and that the MWSA-to-RSA ratio is unrelated to the angiographic severity. Although the MWSA component is also eliminated by intravenous atropine, this component in the standing position also contains ,3-adrenergic-receptormediated activity. [16] [17] [18] [19] The magnitude of the MWSA component shows an increase while standing, and the increase is blocked by intravenous propranolol. [16] [17] [18] [19] 30 Additionally, Pagani et al19 reported that the MWSA-to-RSA ratio provides an index of sympathovagal interaction. Thus, our observation of reduced CCVMWSA is also attributable to reduced vagal cardiac function in CAD, although the result showing that the MWSA-to-RSA ratio did not change in CAD suggests that sympathetic cardiac function is not reduced in CAD.
In this study, breathing was controlled during the measurement of heart rate variability, and age was factored into the comparison of the spectral component magnitude. In a previous study,16 we reported that the CCVRSA in normal subjects correlates negatively with respiration frequency when the subjects quietly breathe to various frequencies (6-20/ Our observation of reduced CCVRSA in CAD supports the findings of earlier studies5-7 indicating reduced vagal cardiac function in CAD. Ryan et a15 have reported that patients 3 months after myocardial infarction show less slowing of heart rate during facial water (00 C) immersion than age-matched controls. Tristani et a16 have reported a diminished change in heart rate during the Valsalva maneuver in coronary patients without heart failure. Bennett et a17 have demonstrated less variation in the RR intervals during deep breathing, less bradycardia during the Valsalva maneuver, and a smaller rise in heart rate during lower body negative pressure in postinfarction patients than in age-matched controls. None of these studies, however, has revealed any relation between the reduced vagal cardiac function and the angiographic findings.
Airaksinen et a18 have evaluated vagal cardiac function in patients with CAD by measuring the range of heart rate variability during deep breat'hing and have analyzed its relation to clinical and angiographic findings. Consistent with this study, they found that CAD is associated with impairment in vagal cardiac function independently of the NYHA class, medication, location of diseased coronary arteries, previous transmural myocardial infarction, and indices of left ventricular function. Inconsistent with this study, however, they failed to find any relation between the impairment in vagal cardiac function and the angiographic severity assessed by the number of narrowed coronary arteries. We think that the following three points contribute to this discrepancy: First, their subjects are thought to be inappropriate for evaluating the effects of the severity of the vascular lesions because the distribution of the sample was strongly inclined toward those with multivessel disease (80% of patients). Second, the deep breathing method they used in the assessment of vagal cardiac function can inflict a temporary imbalance in the cardiovascular system,9 and measured heart rate variability can be considerably affected by factors other than vagal cardiac function. Third, their method is unable to eliminate the effects of sympathetic activity on heart rate variability. 16 Recently, La Rovere et a131 have measured baroreceptor reflex control of heart rate in 78 men, 4 weeks after a first myocardial infarction. They found that the baroreceptor reflex slope relating change of heart rate to change of systolic blood pressure is significantly lower in patients with three-vessel disease than in those with one-vessel disease. Although the afferent mechanism is different between the arterial baroreceptor reflex and the RSA, the results of La Rovere et a131 are consistent with ours, indicating a correlation of the reduced vagal function with the angiographic severity in patients with CAD.
Many mechanisms can contribute to reduced vagal cardiac function in patients with CAD, and they include 1) reaction of the autonomic cardiovascular control against decreased cardiac function, 2) altered autonomic function as a result of long-term restriction of physical activity, 3) effects of cardiovascular medication on the autonomic nervous function, 4) impairment of the sinoatrial nodal function because of ischemia of the sinoatrial node, and 5) ischemic damage of the intrinsic cardiac nerves and cardiac receptors.32 These mechanisms, however, are unlikely to explain the results of the present study for the following respective reasons: 1) although vagal cardiac function decreases in congestive heart failure,33 we excluded those patients with heart failure belonging to NYHA class II or above, and the CCVRSA was unrelated to LVEDP or LVEF; 2) none of the subjects needed any restriction of his or her usual daily activities; 3) we discontinued all medication at least 3 days before the study, and the CCVRSA also appeared to be unaffected by drugs that can have longer effects, such as f-blockers and digitalis; 4) the CCVRSA was unaffected by the presence of stenosis proximal to the origin of or within the sinoatrial node artery; and 5) the CCVRSA was also unaffected by the presence of any previous myocardial infarction, which is expected to cause extensive damage to the intrinsic cardiac nerves and cardiac receptors.34 '35 One possible mechanism that can explain the results of the present study is that reduced vagal cardiac function has an effect on the progression of coronary arteriosclerosis. Kaplan et a136 have shown that cynomolgus macaque monkeys fed an atherogenic diet for 22 months develop coronary atherosclerosis to a different extent depending on their resting heart rate. Monkeys with a habitual high resting heart rate developed lesions in the coronary arteries twofold as extensive as in monkeys with a low resting heart rate. This relation existed independently of serum lipids and blood pressure. Additionally, Perski et a137 have reported a significant association between the minimum and average heart rate recorded during 24-hour continuous monitoring and the severity of coronary atherosclerosis in young male postinfarction patients. This relation seemed to be independent of other established risk factors such as smoking history, systolic and diastolic pressures, and serum lipoproteins. The results of the present study cannot be explained by the relation between the vagal cardiac function and the heart rate because the CCVRSA, the index of vagal cardiac function we used in this study, is a value adjusted for the effect of the mean RR interval in its definition. Thus, reduced vagal cardiac function can also be related to the progression of coronary atherosclerosis. To test this hypothesis, further studies including precise analyses of the interrelation among well-established coronary risk factors and vagal cardiac function should be conducted.
Finally, the results of this study can explain a part of the mechanism involved in increased mortality in CAD patients with decreased vagal function. Many recent studies'-4 have shown that patients with reduced vagal cardiac function assessed by heart rate variability have increased susceptibility to sudden coronary death,',2 increased subsequent mortality after acute myocardial infarction,3 or increased late mortality after coronary angiography.4 Our data suggest that the patients with greater reduction in the vagal cardiac function might have more severe lesions in the coronary arteries.
This study indicates that CAD is associated with vagal dominant impairment in autonomic cardiac function and that the reduction in the vagal cardiac function correlates with the angiographic severity independently of previous myocardial infarction, location of diseased coronary arteries, and left ventricular function. Assessment of autonomic cardiac function by spectral analysis of heart rate variability can provide useful information for the basic pathophysiological understanding and clinical management of CAD.
